Next on the agenda were presentations by the leaders of more established Wyss Zurich projects, describing the projects’ current status and the milestones they have reached so far. The presentations, which detailed the exciting range of topics and what the projects have already been able to achieve, were delivered in a variety of formats, including “live pitches”, videos, and  presentations by the Co-Directors.

The highlight of the evening was a panel discussion with guest of honor Hansjörg Wyss. Together with the project leaders of the alumni projects, ANYbotics, CUTISS (denovoSkin), Cellerys (ETIMSred), and Wingtra, the members of the panel discussed the various topics addressed by the startups and the challenges facing them. As Hansjörg Wyss pointed out, “Startups underestimate how much money and time are needed.”

The universities are working closely together

In their closing remarks, Joël Mesot and Michael E. Schaepman once again expressed their gratitude for Hansjörg Wyss’s initiative. They greatly appreciate the closer cooperation between their two universities that Wyss Zurich has made possible, and were delighted to learn more about the groundbreaking projects, cutting-edge technologies, and remarkable success stories that Wyss Zurich is facilitating. “Wyss Zurich has managed to bring two universities closer together. Thanks to its efforts, they are talking to each other and working together,” Joël Mesot said.

Positive developments and impressive results

All the stakeholders were very positive in their comments and pointed out the need for more institutions and models of this kind in academia. The two Founding Co-Directors emphasized how valuable it is to bring together the fields of Regenerative Medicine and Robotics. Hansjörg Wyss, too, was clearly pleased with what Wyss Zurich has accomplished. The project leaders underscored their profound gratitude for the support they have received.

After nearly seven years of operation, Wyss Zurich can already report notable successes, including multiple startup companies currently in the market.

 

About Wyss Zurich

Wyss Zurich is operated jointly by ETH Zurich and the University of Zurich and was created with the goal of “Translating Science into Life” in the two emerging fields of Regenerative Medicine and Robotics, as well as related hybrid technologies. The aim is to contribute to Zurich’s excellent academic ecosystem by adding a strong hub for clinical translation and technology transfer. Wyss Zurich is currently supporting 13 Wyss Zurich projects and two Outreach projects. All of them receive strong support from the Regenerative Medicine Technology and Robotics Technology platforms.